Connection

Rebecca Bechhold to Trastuzumab

Back to Details
This is a "connection" page, showing publications Rebecca Bechhold has written about Trastuzumab.
Rebecca Bechhold
Connection Strength
0.030
Trastuzumab
  1. Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research Institute. Clin Breast Cancer. 2015 Aug; 15(4):251-8.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.